Skip to main content
. 2021 Mar 10;22(6):2805. doi: 10.3390/ijms22062805
FDA U.S. Food and Drug Administration
CDER The Center for Drug Evaluation and Research
CBER The Center for Biologics Evaluation and Research
WHO World health organization
mAb Monoclonal antibody
bsAb Bispecific antibody
ADC Antibody drug conjugate
CAR T Chimeric antigen receptor T cell
TNF Tumor necrosis factor
GPCR G-protein coupled receptor
GLP-1 Glucagon-like peptide-1
GIP Glucose-dependent insulinotropic polypeptide
AAV Adeno-associated virus
GM-CSF Granulocyte-macrophage colony stimulating factor
ON Oligonucleotide
ASO Antisense oligonucleotide
siRNA Short interfering RNA
GalNac N-acetylgalactosamine
CRISPR Clustered regularly interspaced short palindromic repeats
T1D Type 1 diabetes mellitus
T2D Type 2 diabetes mellitus
HbA1c Hemoglobin A1c
HSC Hematopoietic stem cell
MSC Mesenchymal stem cell
NF-κB Nuclear factor -κB
JAK Janus kinase
STAT Transducer and activator of transcription
SYK Spleen tyrosine kinase
TYK2 Tyrosine kinase 2
BTK Bruton’s tyrosine kinase
AtD Atopic dermatitis
Th T helper
PDE4 Phosphodiesterase 4
EASI Eczema area and severity index
H4R Histamine H4 receptor
MAdCAM Mucosal addressin cell adhesion molecule
S1P Sphingosine 1-phosphate
CNS Central nervous system
OA Osteoarthritis
NSAID Nonsteroidal anti-inflammatory drug
COX Cyclooxygenase
NGF Nerve growth factor
MMP Matrix metalloproteinase
CGRP Calcitonin gene-related peptide
ND Neurodegenerative disease
AD Alzheimer’s disease
PD Parkinson’s disease
AChEIs Acetylcholinesterase inhibitors
NMDA N-methyl-D-aspartic acid
DMTs Disease-modifying treatments